This is just a sampling of medical advancements in 2024 chosen for their common presence in the American population. It is ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

The agency has approved a four-dose version of the drug, called Mounjaro KwikPen, which provides a month’s course of GLP-1 and GIP agonist tirzepatide ... high blood pressure, high cholesterol ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common diabetes drugs.

Monash University researchers have revealed how the gut—and what we eat—regulates high blood pressure, opening the door to ...

Nothing doctors prescribed controlled Michael Garrity’s dangerously high blood pressure — until they zapped away some nerves ...

Nothing doctors prescribed controlled Michael Garrity’s dangerously high blood pressure — until they zapped away some nerves ...

The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have ...

Nov. 21, 2024 — Scientists have discovered how long-term treatment of high blood pressure with commonly prescribed drugs can destroy the kidney's ability to filter and purify blood. The finding ...